Kiyean Nam
Qurient (South Korea)(KR)
Publications by Year
Research Areas
Tuberculosis Research and Epidemiology, Phagocytosis and Immune Regulation, Cancer therapeutics and mechanisms, Immune cells in cancer, Advanced Breast Cancer Therapies
Most-Cited Works
- → Discovery of Q203, a potent clinical candidate for the treatment of tuberculosis(2013)600 cited
- → Lead Optimization of a Novel Series of Imidazo[1,2-a]pyridine Amides Leading to a Clinical Candidate (Q203) as a Multi- and Extensively-Drug-Resistant Anti-tuberculosis Agent(2014)173 cited
- → Telacebec (Q203), a New Antituberculosis Agent(2020)134 cited
- → Glucocorticoid Receptor Antagonism by Cyproterone Acetate and RU486(2003)90 cited
- → Synthesis and structure-activity studies of side chain analogues of the anti-tubercular agent, Q203(2016)40 cited
- → Safety, Tolerability, and Pharmacokinetics of Telacebec (Q203), a New Antituberculosis Agent, in Healthy Subjects(2021)38 cited
- → QSAR Models for Predicting the Similarity in Binding Profiles for Pairs of Protein Kinases and the Variation of Models between Experimental Data Sets(2009)33 cited
- → Simulation of the different biological activities of diethylstilbestrol (DES) on estrogen receptor α and estrogen‐related receptor γ(2002)28 cited
- → Synthesis and structure-activity relationships of novel fused ring analogues of Q203 as antitubercular agents(2017)27 cited
- → p38 MAP kinase inhibitors. Part 6: 2-Arylpyridazin-3-ones as templates for inhibitor design(2006)20 cited